证券代码：002737 证券简称：葵花药业 公告编号：2026-003 葵花药业集团股份有限公司 关于收到易活牌益生菌粉 注册申请受理通知书的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 登录新浪财经APP 搜索【信披】查看更多考评等级 葵花药业集团股份有限公司（以下简称"公司"或"本公司"）全资子公司 哈尔滨葵花药业有限公司于近 日收到国家市场监督管理总局下发的关于"易活牌益生菌粉"注册申请的《受理通知书》，现将有关情况 公告如下： 一、产品的基本情况 产品名称：易活牌益生菌粉 受理号：国食健申G20260026 申请事项：国产保健食品新产品注册 申请人：哈尔滨葵花药业有限公司 结论：根据《中华人民共和国行政许可法》第三十二条的规定，经审查，决定予以受理。 产品功能：本品经动物实验评价，具有有助于增强免疫力的保健功能;有助于润肠通便。 二、风险提示 上述产品在收到国家市场监督管理总局注册申请受理后，将转入国家市场监督管理总局保健食品审评机 构进行审评审批，鉴于产品审评周期长、环节多，期间受不确定性因素影响，具体完成时间、审批结果 存在不确定性。提醒广 ...

Group 1 - Far East Holdings announced that its subsidiary won a contract order worth 3.075 billion yuan, including contracts for green building cables and smart manufacturing cables [1] - Yifan Pharmaceutical received a drug registration certificate for Vitamin K1 injection, which is used to treat vitamin K deficiency-related bleeding [2] - Guangdong Electric Power A's Maoming Bohua Power Plant's Unit 4 has successfully commenced commercial operation, with a total investment of 7.484 billion yuan and an expected annual power generation of 8.6 billion kWh [4] Group 2 - Longfly Fiber reported that the global fiber optic cable industry market environment is normal, with product price fluctuations needing comprehensive assessment [25] - Shanghai Yizhong's net profit for 2025 increased by 819.42%, with total revenue of 317 million yuan, a growth of 82.72% [22] - Guizhou Power's subsidiary received a government subsidy of 200 million yuan [8] Group 3 - Zhongxing Communications plans to invest 117 million yuan in the Jianxing Zhanlu Fund, which focuses on new information technology and advanced manufacturing [10] - Suwen Electric Power's subsidiary established a joint investment fund with a total commitment of 68.5 million yuan, with Suwen contributing 5 million yuan [26] - ST Kaiyuan announced that its stock may face delisting risk due to expected negative net assets for 2025 [27]

Core Viewpoint - Kweichow Moutai's subsidiary Harbin Kweichow Moutai Pharmaceutical Co., Ltd. has received a notice of acceptance for the registration application of "Yihuo Probiotic Powder" from the State Administration for Market Regulation, indicating potential health benefits related to immune enhancement and bowel regulation [1] Group 1 - The product "Yihuo Probiotic Powder" has undergone animal testing and has been evaluated for its health functions [1] - The product is positioned to assist in enhancing immunity and promoting bowel movement [1]

智通财经APP讯，葵花药业(002737.SZ)公告，公司全资子公司哈尔滨葵花药业有限公司于近日收到国家 市场监督管理总局下发的关于"易活牌益生菌粉"注册申请的《受理通知书》。 公告称，本品经动物实验评价，具有有助于增强免疫力的保健功能;有助于润肠通便。 ...

葵花药业公告，全资子公司哈尔滨葵花药业有限公司近日收到国家市场监督管理总局下发的关于"易活 牌益生菌粉"注册申请的《受理通知书》。产品名称为易活牌益生菌粉，受理号为国食健申 G20260026，申请事项为国产保健食品新产品注册，产品功能经动物实验评价，具有有助于增强免疫力 和润肠通便的保健功能。 ...